Skip to main content
. 2012 Oct 15;31(3):337–343. doi: 10.1200/JCO.2012.43.2674

Fig 3.

Fig 3.

Kaplan-Meier estimates of overall survival by genotype for procarbazine, lomustine, and vincristine plus radiotherapy arm. The hazard ratio (HR) for overall survival of patients with 1p/19q codeleted anaplastic oligodendroglioma (AO)/anaplastic oligoastrocytoma (AOA) compared with those with AO/AOA in whom one or neither allele was deleted was 0.36 (95% CI, 0.23 to 0.57; P < .001).